Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV

Hepatitis C virus (HCV) represents a major global health challenge and an efficient vaccine is urgently needed. Many HCV vaccination strategies employ recombinant versions of the viral E2 glycoprotein. However, recombinant E2 readily forms disulfide-bonded aggregates that might not be optimally suit...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Vaccines (Basel)
Glavni autori: Marín, María Q., Sliepen, Kwinten, García-Arriaza, Juan, Koekkoek, Sylvie M., Pérez, Patricia, Sorzano, Carlos Óscar S., Gómez, Carmen E., Sanders, Rogier W., Esteban, Mariano
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7563715/
https://ncbi.nlm.nih.gov/pubmed/32764419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8030440
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items